These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 33771164)

  • 21. The impact of harm reduction on HIV and illicit drug use.
    Ti L; Kerr T
    Harm Reduct J; 2014 Feb; 11():7. PubMed ID: 24559062
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A drug use survey among clients of harm reduction sites across British Columbia, Canada, 2012.
    Kuo M; Shamsian A; Tzemis D; Buxton JA
    Harm Reduct J; 2014 Apr; 11():13. PubMed ID: 24766846
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 'Peer' work as precarious: A qualitative study of work conditions and experiences of people who use drugs engaged in harm reduction work.
    Greer A; Bungay V; Pauly B; Buxton J
    Int J Drug Policy; 2020 Nov; 85():102922. PubMed ID: 32911320
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Cedar Project: a comparison of HIV-related vulnerabilities amongst young Aboriginal women surviving drug use and sex work in two Canadian cities.
    Mehrabadi A; Craib KJ; Patterson K; Adam W; Moniruzzaman A; Ward-Burkitt B; Schechter MT; Spittal PM;
    Int J Drug Policy; 2008 Apr; 19(2):159-68. PubMed ID: 17870461
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Walk With Me: reducing harm and confronting the toxic drug poisoning crisis in small British Columbia cities through community engaged research.
    Wideman T; Karsten S;
    Harm Reduct J; 2024 May; 21(1):106. PubMed ID: 38822343
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mapping violence and policing as an environmental-structural barrier to health service and syringe availability among substance-using women in street-level sex work.
    Shannon K; Rusch M; Shoveller J; Alexson D; Gibson K; Tyndall MW;
    Int J Drug Policy; 2008 Apr; 19(2):140-7. PubMed ID: 18207725
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High variability of HIV and HCV seroprevalence and risk behaviours among people who inject drugs: results from a cross-sectional study using respondent-driven sampling in eight German cities (2011-14).
    Wenz B; Nielsen S; Gassowski M; Santos-Hövener C; Cai W; Ross RS; Bock CT; Ratsch BA; Kücherer C; Bannert N; Bremer V; Hamouda O; Marcus U; Zimmermann R;
    BMC Public Health; 2016 Sep; 16(1):927. PubMed ID: 27595567
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Understanding experiences of and rationales for sharing crack-smoking equipment: A qualitative study with persons who smoke crack in Montréal.
    Poliquin H; Bertrand K; Flores-Aranda J; Roy É
    Int J Drug Policy; 2017 Oct; 48():18-26. PubMed ID: 28666203
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Urgent Need to Respond to HIV- and HCV-Related Risk Practices among Youth in Ottawa Who Smoke Crack.
    Leonard LE; Wilson L; Germain A; Pelude L; Vannice S
    Subst Use Misuse; 2021; 56(1):1-10. PubMed ID: 33086934
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intimate partner violence and receptive syringe sharing among women who inject drugs in Indonesia: A respondent-driven sampling study.
    Stoicescu C; Cluver LD; Spreckelsen TF; Mahanani MM; Ameilia R
    Int J Drug Policy; 2019 Jan; 63():1-11. PubMed ID: 30465966
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Factors associated with self-reported avoidance of harm reduction services during the COVID-19 pandemic by people who use drugs in five cities in the United States and Canada.
    Feder KA; Choi J; Schluth CG; Hayashi K; DeBeck K; Milloy MJ; Kirk GD; Mehta SH; Kipke M; Moore RD; Baum MK; Shoptaw S; Gorbach PM; Mustanski B; Javanbakht M; Siminski S; Genberg BL
    Drug Alcohol Depend; 2022 Dec; 241():109544. PubMed ID: 35779987
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Harm reduction calls to action from young people who use drugs on the streets of Vancouver and Lisbon.
    Canêdo J; Sedgemore KO; Ebbert K; Anderson H; Dykeman R; Kincaid K; Dias C; Silva D; ; Charlesworth R; Knight R; Fast D
    Harm Reduct J; 2022 May; 19(1):43. PubMed ID: 35505320
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Organizational support for frontline harm reduction and systems navigation work among workers with living and lived experience: qualitative findings from British Columbia, Canada.
    Greer A; Buxton JA; Pauly B; Bungay V
    Harm Reduct J; 2021 Jun; 18(1):60. PubMed ID: 34090473
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Opportunities to learn and barriers to change: crack cocaine use in the Downtown Eastside of Vancouver.
    Boyd S; Johnson JL; Moffat B
    Harm Reduct J; 2008 Nov; 5():34. PubMed ID: 19014696
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Cedar Project: impacts of policing among young Aboriginal people who use injection and non-injection drugs in British Columbia, Canada.
    Pan SW; Christian CW; Pearce ME; Blair AH; Jongbloed K; Zhang H; Teegee M; Thomas V; Schechter MT; Spittal PM
    Int J Drug Policy; 2013 Sep; 24(5):449-59. PubMed ID: 23731672
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Meaningful engagement of people living with HIV who use drugs: methodology for the design of a Peer Research Associate (PRA) hiring model.
    Closson K; McNeil R; McDougall P; Fernando S; Collins AB; Baltzer Turje R; Howard T; Parashar S
    Harm Reduct J; 2016 Oct; 13(1):26. PubMed ID: 27717364
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Peer support using a mobile access van promotes safety and harm reduction strategies among sex trade workers in Vancouver's Downtown Eastside.
    Janssen PA; Gibson K; Bowen R; Spittal PM; Petersen KL
    J Urban Health; 2009 Sep; 86(5):804-9. PubMed ID: 19533367
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Management and Point-of-Care for Tobacco Dependence (PROMPT): a feasibility mixed methods community-based participatory action research project in Ottawa, Canada.
    Pakhale S; Kaur T; Charron C; Florence K; Rose T; Jama S; Boyd R; Haddad J; Alvarez G; Tyndall M
    BMJ Open; 2018 Jan; 8(1):e018416. PubMed ID: 29371273
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Whither RDS? An investigation of Respondent Driven Sampling as a method of recruiting mainstream marijuana users.
    Hathaway AD; Hyshka E; Erickson PG; Asbridge M; Brochu S; Cousineau MM; Duff C; Marsh D
    Harm Reduct J; 2010 Jul; 7():15. PubMed ID: 20618944
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Improving health and social care relationships for harm reduction.
    Allman D; Myers T; Schellenberg J; Strike C; Cockerill R; Cavalieri W
    Int J Drug Policy; 2007 May; 18(3):194-203. PubMed ID: 17689366
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.